Briefly, FSTL1 overexpression stimulates the Wnt/β-catenin pathway to induce tumorigenesis and cancer stem cell maintenance [16,17] and inhibits the BMP2 pathway, which results in the undifferentiation of cancer cells. Here, FSTL1 is linked to cancer.